CN103483625B - 可吸收降解的多用途生物相容性材料 - Google Patents
可吸收降解的多用途生物相容性材料 Download PDFInfo
- Publication number
- CN103483625B CN103483625B CN201310403737.3A CN201310403737A CN103483625B CN 103483625 B CN103483625 B CN 103483625B CN 201310403737 A CN201310403737 A CN 201310403737A CN 103483625 B CN103483625 B CN 103483625B
- Authority
- CN
- China
- Prior art keywords
- aqueous solution
- chitosan
- hyaluronic acid
- mixed
- sodium alginate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000560 biocompatible material Substances 0.000 title claims abstract description 25
- 229920001661 Chitosan Polymers 0.000 claims abstract description 64
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 56
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 53
- 102000008186 Collagen Human genes 0.000 claims abstract description 53
- 108010035532 Collagen Proteins 0.000 claims abstract description 53
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 53
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 42
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 42
- 239000000661 sodium alginate Substances 0.000 claims abstract description 42
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 42
- 229920001436 collagen Polymers 0.000 claims abstract description 24
- 239000000017 hydrogel Substances 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 238000004132 cross linking Methods 0.000 claims abstract description 5
- 229940045110 chitosan Drugs 0.000 claims abstract description 3
- 239000007864 aqueous solution Substances 0.000 claims description 84
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 238000003756 stirring Methods 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 25
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 18
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 claims description 17
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 16
- 239000012153 distilled water Substances 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 230000008961 swelling Effects 0.000 claims description 7
- 230000006196 deacetylation Effects 0.000 claims description 6
- 238000003381 deacetylation reaction Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 3
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 3
- 229940099552 hyaluronan Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- 208000032843 Hemorrhage Diseases 0.000 abstract description 13
- 230000000740 bleeding effect Effects 0.000 abstract description 7
- 230000035876 healing Effects 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 230000008520 organization Effects 0.000 abstract description 4
- 230000003612 virological effect Effects 0.000 abstract description 4
- 210000001519 tissue Anatomy 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002439 hemostatic effect Effects 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000031737 Tissue Adhesions Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000515 collagen sponge Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- -1 poly(lactic acid) Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 229940058573 b-d glucose Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010041 electrostatic spinning Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310403737.3A CN103483625B (zh) | 2013-09-09 | 2013-09-09 | 可吸收降解的多用途生物相容性材料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310403737.3A CN103483625B (zh) | 2013-09-09 | 2013-09-09 | 可吸收降解的多用途生物相容性材料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103483625A CN103483625A (zh) | 2014-01-01 |
CN103483625B true CN103483625B (zh) | 2015-09-23 |
Family
ID=49824250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310403737.3A Active CN103483625B (zh) | 2013-09-09 | 2013-09-09 | 可吸收降解的多用途生物相容性材料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103483625B (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104083455B (zh) * | 2014-06-25 | 2016-09-07 | 湖南中医药大学 | 用于预防或治疗牙周病的组合物、牙齿咬合器及制作方法 |
CN105327383A (zh) * | 2015-09-10 | 2016-02-17 | 中国人民解放军海军医学研究所 | 一种胶原蛋白/海藻酸钙/壳聚糖复合止血海绵及制备方法 |
CN105396171A (zh) * | 2015-11-19 | 2016-03-16 | 耿文真 | 具有抗菌消炎功效的医用膜及其制备工艺 |
CN105997859B (zh) * | 2016-07-08 | 2019-01-15 | 上海建华精细生物制品有限公司 | 小关节治疗用纳米注射液及其制备方法 |
EP3485921A4 (en) | 2016-07-13 | 2020-03-11 | Mochida Pharmaceutical Co., Ltd. | ADHESION PREVENTING COMPOSITION |
CN106310359A (zh) * | 2016-08-29 | 2017-01-11 | 桂林新艺制冷设备有限责任公司 | 一种复合生物材料 |
CN108210987B (zh) * | 2016-12-14 | 2021-01-22 | 沈阳何氏眼产业集团有限公司 | 白内障手术切口用粘合剂及其制备方法 |
CN106832440B (zh) * | 2017-03-10 | 2019-08-09 | 杨季冬 | 一种利用壳聚糖、藻酸钠共聚体系制备柔性胶囊膜的方法 |
CN107189119B (zh) * | 2017-07-24 | 2020-06-16 | 浙江景嘉医疗科技有限公司 | 一种复合玻尿酸胶原蛋白水凝胶的制备方法及其应用 |
CN107823699B (zh) * | 2017-11-17 | 2021-03-30 | 陕西慧康生物科技有限责任公司 | 止血防粘连膜及其制备方法 |
CN108939140A (zh) * | 2018-08-14 | 2018-12-07 | 中山大学 | 一种用于止血的组合物及医用止血敷料 |
CN109045356A (zh) * | 2018-09-08 | 2018-12-21 | 佛山市森昂生物科技有限公司 | 一种活性生物膜组织修补材料的制备方法 |
CN111057364B (zh) * | 2019-12-31 | 2021-12-24 | 义乌市比沃科日用品有限公司 | 一种可拼接高回弹地垫 |
CN111978600B (zh) * | 2020-09-02 | 2022-07-01 | 山东华熙海御生物医药有限公司 | 一种用于安抚奶嘴的透明质酸复合凝胶 |
CN112245330B (zh) * | 2020-10-27 | 2022-10-11 | 杭州华玮生物科技有限公司 | 一种化妆品原料的冻干产品的非制冷成型的方法及复溶方法 |
CN113754919B (zh) * | 2021-09-27 | 2022-04-29 | 江南大学 | 一种快速吸血、孔道有序的止血海绵的制备及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1382425A (zh) * | 2002-05-14 | 2002-12-04 | 暨南大学 | 生物诱导型活性人工角膜及其制备方法 |
CN1788802A (zh) * | 2005-12-14 | 2006-06-21 | 温州医学院 | 促创伤修复生物海绵材料及其制备方法 |
CN101632841A (zh) * | 2009-08-21 | 2010-01-27 | 暨南大学 | 含海藻酸盐、糖胺聚糖和胶原的组织工程支架及其制备方法 |
CN101816802A (zh) * | 2010-02-05 | 2010-09-01 | 佘振定 | 一种壳聚糖基医用敷料 |
-
2013
- 2013-09-09 CN CN201310403737.3A patent/CN103483625B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1382425A (zh) * | 2002-05-14 | 2002-12-04 | 暨南大学 | 生物诱导型活性人工角膜及其制备方法 |
CN1788802A (zh) * | 2005-12-14 | 2006-06-21 | 温州医学院 | 促创伤修复生物海绵材料及其制备方法 |
CN101632841A (zh) * | 2009-08-21 | 2010-01-27 | 暨南大学 | 含海藻酸盐、糖胺聚糖和胶原的组织工程支架及其制备方法 |
CN101816802A (zh) * | 2010-02-05 | 2010-09-01 | 佘振定 | 一种壳聚糖基医用敷料 |
Also Published As
Publication number | Publication date |
---|---|
CN103483625A (zh) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103483625B (zh) | 可吸收降解的多用途生物相容性材料 | |
JP6868314B2 (ja) | ヒアルロン酸−カルシウム及びポリリシンを含む創傷被覆材及びその製造方法 | |
Tang et al. | Application of chitosan and its derivatives in medical materials | |
US9533005B2 (en) | Modified starch material of biocompatible hemostasis | |
CN102600013B (zh) | 一种医用植绒止血材料及其制备和应用 | |
CN101485897B (zh) | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 | |
US20070254016A1 (en) | Biodegradable foam | |
CN101121041A (zh) | 变性淀粉可吸收性止血材料及其制备方法 | |
JP2006514843A (ja) | キトサンと酸化セルロースとを含有する創傷包帯用組成物 | |
CN101537205A (zh) | 一种可降解型医用止血防粘连材料及其制备方法 | |
CN104906626A (zh) | 可吸收降解的生物相容性止血材料及其制备方法 | |
CN111588902A (zh) | 一种大面积创伤急救敷料及其制备方法 | |
Mohamed et al. | The role of nanoscale structures in the development of topical hemostatic agents | |
CN103920182B (zh) | 一种生物可吸收止血膜 | |
CN104208741A (zh) | 一种壳聚糖基创口贴 | |
CN104307031B (zh) | 一种皮肤外用修复材料的制备方法及用途 | |
CN1589912A (zh) | 可吸收降解止血防粘连材料 | |
CN109731128A (zh) | 一种可吸收降解的生物相容性止血材料及其制备方法 | |
CN108578749A (zh) | 一种可载药缓释的医用复合柚皮果胶海绵敷料及其制备方法和应用 | |
CN107715167A (zh) | 作为骨蜡替代物的壳聚糖基止血糊剂及制备方法 | |
CN104225664A (zh) | 壳聚糖组合物 | |
CN114748677B (zh) | 一种抗粘连的水凝胶粘合剂及制备方法、应用 | |
WO2018082090A1 (en) | Biological tissue-reinforcing material and artificial dura mater | |
KR102546437B1 (ko) | 생체적합성 고분자를 포함하는 파우더형 유착방지제 및 그의 제조방법 | |
Susrutha et al. | Types of Wound Dressings and Materials used in Mild to Moderately Exuding Wounds: A Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171023 Address after: 310000, Wanyuan Road 1, Shushan street, Xiaoshan District, Zhejiang, Hangzhou Patentee after: Hangzhou Kin Kin Biotechnology Co., Ltd. Address before: Xiaoshan District of Hangzhou City, Zhejiang province 310000 Wai Town Bridge Development Zone Spring Road No. 1 Patentee before: Dai Jianying |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Absorbable and degradable multipurpose biocompatible materials Effective date of registration: 20220228 Granted publication date: 20150923 Pledgee: Xiaoshan sub branch of Hangzhou United Rural Commercial Bank Co.,Ltd. Pledgor: HANGZHOU YINGJIAN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022330000268 |